Your browser doesn't support javascript.
loading
Deletion of fibroblast activation protein provides atheroprotection.
Stein, Sokrates; Weber, Julien; Nusser-Stein, Stefanie; Pahla, Jürgen; Zhang, Hui E; Mohammed, Shafeeq A; Oppi, Sara; Gaul, Daniel S; Paneni, Francesco; Tailleux, Anne; Staels, Bart; von Meyenn, Ferdinand; Ruschitzka, Frank; Gorrell, Mark D; Lüscher, Thomas F; Matter, Christian M.
Afiliação
  • Stein S; Center for Molecular Cardiology, University of Zurich, Wagistrasse 12, CH-8952 Schlieren, Switzerland.
  • Weber J; Department of Cardiology, University Heart Center Zurich, University Hospital Zurich, Raemistrasse 100, CH-8091 Zurich, Switzerland.
  • Nusser-Stein S; Center for Molecular Cardiology, University of Zurich, Wagistrasse 12, CH-8952 Schlieren, Switzerland.
  • Pahla J; Center for Molecular Cardiology, University of Zurich, Wagistrasse 12, CH-8952 Schlieren, Switzerland.
  • Zhang HE; Center for Molecular Cardiology, University of Zurich, Wagistrasse 12, CH-8952 Schlieren, Switzerland.
  • Mohammed SA; Liver Enzymes in Metabolism and Inflammation Program, Centenary Institute, The University of Sydney Faculty of Medicine and Health, Sydney, NSW 2050, Liver Enzymes in Metabolism and Inflammation Program, Centenary Institute, Australia.
  • Oppi S; Center for Molecular Cardiology, University of Zurich, Wagistrasse 12, CH-8952 Schlieren, Switzerland.
  • Gaul DS; Center for Molecular Cardiology, University of Zurich, Wagistrasse 12, CH-8952 Schlieren, Switzerland.
  • Paneni F; Center for Molecular Cardiology, University of Zurich, Wagistrasse 12, CH-8952 Schlieren, Switzerland.
  • Tailleux A; Center for Molecular Cardiology, University of Zurich, Wagistrasse 12, CH-8952 Schlieren, Switzerland.
  • Staels B; Department of Cardiology, University Heart Center Zurich, University Hospital Zurich, Raemistrasse 100, CH-8091 Zurich, Switzerland.
  • von Meyenn F; Department of Research and Education, University Hospital Zurich, Raemistrasse 100, CH-8091 Zurich, Switzerland.
  • Ruschitzka F; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, Lille, 42 Rue Paul Duez, 59000 Lille, France.
  • Gorrell MD; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, Lille, 42 Rue Paul Duez, 59000 Lille, France.
  • Lüscher TF; Department of Health Sciences and Technology, Institute of Food, Nutrition and Health, Department of Health Sciences and Technology, ETH Zurich, Schorenstrasse 16 CH-8603 Schwerzenbach, Switzerland.
  • Matter CM; Department of Cardiology, University Heart Center Zurich, University Hospital Zurich, Raemistrasse 100, CH-8091 Zurich, Switzerland.
Cardiovasc Res ; 117(4): 1060-1069, 2021 03 21.
Article em En | MEDLINE | ID: mdl-32402085

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aorta / Doenças da Aorta / Endopeptidases / Aterosclerose / Remodelação Vascular / Proteínas de Membrana Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aorta / Doenças da Aorta / Endopeptidases / Aterosclerose / Remodelação Vascular / Proteínas de Membrana Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article